検索結果

d by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the long-term use of contact lenses, and the widespread use of Visual Display Term...

千寿製薬株式会社

a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 查看新闻 非处方类产品等

お知らせ | 千寿製薬株式会社

a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”...

临床试验信息 | 研究与开发 | 千寿制药株式会社

te that the information may differ from the up-to-date information depending on when it is updated. Agree Disagree

vative. BAC is widely used in eye drops but it is known to occasionally cause corneal epithelial damage1. Our goal was to develop a formulation that maintains the efficacy of the previous formulation ...